Immunodiagnostic Systems Holdings plc (IDH) - Medical Equipment - Deals and Alliances Profile
December 2018
41
About the Report
About the Report
Summary
Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.
Immunodiagnostic Systems Holdings plc (IDH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Immunodiagnostic Systems Holdings plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deal Details 10
Partnerships 10
Immunodiagnostic Systems Enters into Agreement with Technogenetics 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Acquisition 15
Immunodiagnostic Acquires Diametra, Medical Device Company 15
Immunodiagnostic Systems Holdings plc-Key Competitors 16
Immunodiagnostic Systems Holdings plc-Key Employees 17
Immunodiagnostic Systems Holdings plc-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Oct 19, 2018: Immunodiagnostic Systems: H1 Trading Update 19
Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 21
Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 26
Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 32
Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 33
Corporate Communications 34
Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018 34
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 35
Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 36
Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 37
Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 38
Product News 39
Apr 04, 2018: Meet IDS at MEDLAB Asia Pacific 2018 from the 2 nd until the 4 th of April 39
Other Significant Developments 40
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Figure
List of Figures
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Immunodiagnostic Systems Holdings plc, Medical Equipment, Key Facts, 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunodiagnostic Systems Holdings plc, Deals By Market, 2012 to YTD 2018 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immunodiagnostic Systems Enters into Agreement with Technogenetics 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Immunodiagnostic Acquires Diametra, Medical Device Company 15
Immunodiagnostic Systems Holdings plc, Key Competitors 16
Immunodiagnostic Systems Holdings plc, Key Employees 17
Immunodiagnostic Systems Holdings plc, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.